(Q44586465)

4 December 2017

Optic nerve atrophy in propionic acidemia (English)

1 reference

4 December 2017

Tsontcho Ianchulev

1

1 reference

4 December 2017

Talia Kolin

series ordinal

2

1 reference

4 December 2017

Kathryn Moseley

series ordinal

3

1 reference

4 December 2017

Alfredo Sadun

series ordinal

4

1 reference

4 December 2017

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

110

1 reference

4 December 2017

9

1 reference

4 December 2017

1850-1854

1 reference

Propionic acidemia: a clinical update

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Movement disorders in childhood organic acidurias. Clinical, neuroimaging, and biochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Neonatal-onset propionic acidemia: neurologic and developmental profiles, and implications for management.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

3-Methylglutaconic aciduria in "optic atrophy plus".

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Magnetic resonance spectroscopy (MRS) in five patients with treated propionic acidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in propionic acidemia: clinical and MRI correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

A mitochondrial DNA tRNA(Val) point mutation associated with adult-onset Leigh syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Cytochrome c oxidase deficiency in Leigh syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Familial Leigh's syndrome: association with a defect in oxidative metabolism probably restricted to brain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Clinical presentation of mitochondrial respiratory chain defects in NADH-coenzyme Q reductase and cytochrome oxidase: clues to pathogenesis of Leigh disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Neonatal exposure to D,L-2-amino-3-phosphonopropionate (D,L-AP3) produces lesions in the eye and optic nerve of adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Propionic and L-methylmalonic acids induce oxidative stress in brain of young rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Inhibition of glutamate uptake into synaptic vesicles from rat brain by 3-nitropropionic acid in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

The molecular genetics of Leber's hereditary optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Ophthalmoscopic findings in Leber's hereditary optic neuropathy. I. Fundus findings in asymptomatic family members

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

Leber's hereditary optic neuroretinopathy, a mitochondrial disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900573-6

7 January 2021

10.1016/S0161-6420(03)00573-6

Identifiers

DOI

1 reference

4 December 2017

1 reference